DAWN·23954D109·US·equity·Healthcare - Biotechnology-Activist
DAWN (DAY ONE BIOPHARMACEUTICALS I) is held by 113 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($151M), FIL Ltd ($88.6M), JPMORGAN CHASE & CO ($67.1M). Net institutional sentiment: Mixed.
See how DAWN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer